TY - JOUR
T1 - Studies in humans and mice implicate neurocan in the etiology of mania
AU - Miró, Xavier
AU - Meier, Sandra
AU - Dreisow, Marie Luise
AU - Frank, Josef
AU - Strohmaier, Jana
AU - Breuer, René
AU - Schmäl, Christine
AU - Albayram, Önder
AU - Pardo-Olmedilla, María Teresa
AU - Mühleisen, Thomas W.
AU - Degenhardt, Franziska A.
AU - Mattheisen, Manuel
AU - Reinhard, Iris
AU - Bilkei-Gorzo, Andras
AU - Cichon, Sven
AU - Seidenbecher, Constanze
AU - Rietschel, Marcella
AU - Nöthen, Markus M.
AU - Zimmer, Andreas
PY - 2012/8/1
Y1 - 2012/8/1
N2 - Objective: Genome-wide association has been reported between the NCAN gene and bipolar disorder. The aims of this study were to characterize the clinical symptomatology most strongly influenced by NCAN and to explore the behavioral phenotype of Ncan knockout (Ncan-/-) mice. Method: Genotype/phenotype correlations were investigated in patients with bipolar disorder (N=641) and the genetically related disorders major depression (N=597) and schizophrenia (N=480). Principal components and genotype association analyses were used to derive main clinical factors from 69 lifetime symptoms and to determine which of these factors were associated with the NCAN risk allele. These analyses were then repeated using the associated factor(s) only in order to identify the more specific clinical subdimensions that drive the association. Ncan-/- mice were tested using diverse paradigms, assessing a range of behavioral traits, including paradigms corresponding to bipolar symptoms in humans. Results: In the combined patient sample, the NCAN risk allele was significantly associated with the "mania" factor, in particular the subdimension "overactivity."Ncan-/- mice were hyperactive and showed more frequent risk-taking and repetitive behaviors, less depression-like conduct, impaired prepulse inhibition, amphetamine hypersensitivity, and increased saccharin preference. These aberrant behavioral responses normalized after the administration of lithium. Conclusions: NCAN preferentially affected mania symptoms in humans. Ncan-/- mice showed behavioral abnormalities that were strikingly similar to those of the humanmania phenotype and may thus serve as a valid mouse model.
AB - Objective: Genome-wide association has been reported between the NCAN gene and bipolar disorder. The aims of this study were to characterize the clinical symptomatology most strongly influenced by NCAN and to explore the behavioral phenotype of Ncan knockout (Ncan-/-) mice. Method: Genotype/phenotype correlations were investigated in patients with bipolar disorder (N=641) and the genetically related disorders major depression (N=597) and schizophrenia (N=480). Principal components and genotype association analyses were used to derive main clinical factors from 69 lifetime symptoms and to determine which of these factors were associated with the NCAN risk allele. These analyses were then repeated using the associated factor(s) only in order to identify the more specific clinical subdimensions that drive the association. Ncan-/- mice were tested using diverse paradigms, assessing a range of behavioral traits, including paradigms corresponding to bipolar symptoms in humans. Results: In the combined patient sample, the NCAN risk allele was significantly associated with the "mania" factor, in particular the subdimension "overactivity."Ncan-/- mice were hyperactive and showed more frequent risk-taking and repetitive behaviors, less depression-like conduct, impaired prepulse inhibition, amphetamine hypersensitivity, and increased saccharin preference. These aberrant behavioral responses normalized after the administration of lithium. Conclusions: NCAN preferentially affected mania symptoms in humans. Ncan-/- mice showed behavioral abnormalities that were strikingly similar to those of the humanmania phenotype and may thus serve as a valid mouse model.
UR - http://www.scopus.com/inward/record.url?scp=84865845956&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84865845956&partnerID=8YFLogxK
U2 - 10.1176/appi.ajp.2012.11101585
DO - 10.1176/appi.ajp.2012.11101585
M3 - Article
C2 - 22952076
AN - SCOPUS:84865845956
SN - 0002-953X
VL - 169
SP - 982
EP - 990
JO - American Journal of Psychiatry
JF - American Journal of Psychiatry
IS - 9
ER -